Saffron Cognitive Performance Meta-analysis: What the Evidence Says

Quick Answer

Saffron Cognitive Performance Meta-analysis has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are systematic review, so conclusions should be framed as evidence-aware guidance rather than medical advice.

Key Takeaways

• This page is generated only from sources stored in the Migaku evidence knowledge base.
• Current evidence mix: 1 systematic review, 1 narrative review.
• Claims should be interpreted with the source type, study design, population, and publication date in mind.
• This article is educational and does not replace care from a qualified clinician.

Evidence Map

What The Sources Report

• In general, risk of bias in selective reporting and incomplete data were low, and bias regarding inclusion of intention-to-treat analysis was low to moderate. [Ho Chao-Yen (2026); evidence level 1]
• The analysis revealed a pooled SMD (pSMD) = 1.20 (95 % confidence interval to 1.76), indicating that taking herbal dietary supplements was associated with a greater improvement in erectile function as compared to controls. [Ho Chao-Yen (2026); evidence level 1]
• In recent years, a growing body of scientific evidence supporting several of these traditional uses has shown the potential of saffron and its main ingredients-crocins, crocetin, safranal, and picrocrocin-as pharmacologically relevant compounds. [Campos Catarina (2026); evidence level 3]
• By integrating evidence from in vitro studies, animal models, and clinical trials, this review critically assesses saffron's potential as a multi-target pharmacological agent and identifies key limitations and future directions for its development within pharmaceutical and integrative medicine frameworks. [Campos Catarina (2026); evidence level 3]

How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

Practical Interpretation

There is at least one systematic-review style source in the current set, so it deserves more weight than single-study evidence. For saffron cognitive performance meta-analysis, the next editorial step is to add more targeted sources and separate strong findings from early or indirect evidence.

Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

References

• Ho Chao-Yen (2026). Herbal dietary supplements for erectile dysfunction: A systematic review and meta-analysis of randomized-controlled trials. DOI: 10.1016/j.jtcme.2025.11.001. PMCID: PMC12902307. PMID: 41696741. License: https://creativecommons.org/licenses/by-nc-nd/4.0/. https://pmc.ncbi.nlm.nih.gov/articles/PMC12902307/
• Campos Catarina (2026). From Stigma to Therapy: Pharmacological Insights into Saffron Bioactives for Major Non-Communicable Diseases. DOI: 10.3390/ph19030484. PMCID: PMC13029429. PMID: 41901329. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13029429/

Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.